Stem cell therapies across multiple disciplines continue to demonstrate promising results. How successful are autologous cardiac stem cell treatments proving to be at regenerating cardiac tissue after a heart attack? Which patients would be the best candidates for this procedure, and when might this treatment move from clinical trials into the clinic? Dr. Eduardo Marbán, director of the Cedars-Sinai Heart Institute, developed this procedure, and joins host Dr. Janet Wright to discuss its exciting applications.
Can Autologous Stem Cells Reverse the Damage of a Heart Attack?

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Stem cell therapies across multiple disciplines continue to demonstrate promising results. How successful are autologous cardiac stem cell treatments proving to be at regenerating cardiac tissue after a heart attack? Which patients would be the best candidates for this procedure, and when might this treatment move from clinical trials into the clinic? Dr. Eduardo Marbán, director of the Cedars-Sinai Heart Institute, developed this procedure, and joins host Dr. Janet Wright to discuss its exciting applications.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Love Story: Lipid Education for Women’s Heart Health
HF Management for Patients with Comorbid Conditions
Navigating Myasthenia Gravis in Adolescents and Young Adults
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?